Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial enzymes and proteins containing thiol residues represent a broad class of molecular targets essential for microbial survival, encompassing roles in metabolism, structural stability, and redox regulation (Russell & Hugo, 1994). Thiol (sulfhydryl) groups, primarily found on cysteine residues, are critical for the catalytic function of numerous enzymes and the maintenance of cellular homeostasis (NIH, 2023). Antimicrobial agents such as silver ions, organomercurials, and auranofin exert their bactericidal effects by covalently binding to these thiol groups, which results in enzyme inactivation and protein denaturation (PNAS, 2013; NIH, 2023). This process often triggers the production of reactive oxygen species (ROS), further damaging the bacterial cell (MDPI, 2023). While these targets are highly effective for broad-spectrum activity, their ubiquity in human cells poses significant risks of systemic toxicity and adverse effects like argyria or neurotoxicity (NIH, 2020; NIH, 2023). Modern research focuses on identifying specific bacterial thiol-dependent systems, such as thioredoxin reductase, to develop more selective and safer therapeutic agents (PNAS, 2013).
Antimicrobial agents target these proteins by covalently binding to the sulfhydryl (-SH) groups of cysteine residues, which inactivates essential enzymes and denatures structural proteins (Russell & Hugo, 1994; NIH, 2023). This interaction disrupts the bacterial redox balance, often leading to the accumulation of reactive oxygen species (ROS) and subsequent cell death (PNAS, 2013; MDPI, 2023).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial enzymes and proteins containing thiol residues.